Cellivery Therapeutics, Inc. (KOSDAQ:A268600) agree to acquire Ajin Clean Co., Ltd. from SVAJ Holdings for KRW 14.9 billion on November 16, 2021. Under the terms of agreement, Cellivery Therapeutics, Inc will acquire 0.1 million shares. Ajin Clean Co reported total assets of KRW 24.6 billion, total revenue of KRW 37.1 billion, total common equity of KRW 9.4 billion and total income of KRW 1.1 billion for the year ending December 31, 2021.

KPMG Samjong Accounting Corp acted as external evaluation agency in the deal.